Why Modern Cancer Treatment Might Be Making Things Worse w/ Georgi Dinkov

Georgie's Revolutionary Approach to Cancer Treatment

Challenging Mainstream Cancer Models

• Georgie argues against the mainstream cancer model, suggesting that estrogen contributes to cancer rather than being solely harmful.

• He observes tumor reversal by using compounds contrary to those recommended by mainstream medicine for prostate cancer treatment.

Historical Context and Research Insights

• A reference is made to a 30-year-old article by Ry, which discusses how estrogen drives cancer metabolism and testosterone's opposing effects on it.

Current Events Impacting Research

• Georgie notes that the DC budget is facing cuts, particularly affecting police services amidst rising crime concerns.

• The local housing market is experiencing a downturn due to federal layoffs, potentially benefiting younger generations seeking affordable homes.

Funding Independence in Research

• Georgie's research studies are self-funded, highlighting his commitment to science without reliance on government funding.

• He expresses skepticism about the federal funding process, citing its restrictive nature and potential conflicts of interest.

The Importance of Autonomy in Scientific Inquiry

• Georgie emphasizes maintaining independence in research to pursue genuine scientific inquiries rather than conforming to external pressures for funding.

• He reflects on his experiences in grad school where he learned that many research ideas are dictated by what can secure funding from federal agencies.

Bioenergetic View of Cancer

• The discussion revisits the bioenergetic view of cancer, explaining how energy metabolism failures lead cells towards glycolysis and the Warburg effect.

• It’s noted that while there are multiple pathways for energy production in healthy cells, cancer cells often rely on less efficient methods when primary pathways fail.

Understanding Cancer Metabolism and Treatment

The Role of Glycolysis in Energy Production

• Pete discusses the potential of reversing glycolysis to restore proper oxidative phosphorylation, suggesting this could lead to cancer cures.

• Glycolysis is crucial for processes like wound healing, where cells temporarily switch from oxidative phosphorylation to rapidly divide and grow.

• While glycolysis aids initial tissue repair, it results in undifferentiated cells that must later transition back to oxidative phosphorylation for proper tissue formation.

Differentiation and Cancer Metabolism

• For new tissue to differentiate into specific types (muscle, tendon, bone), oxidative phosphorylation must be reactivated to produce necessary hormones.

• Continuous assaults on healthy tissue can lead cells to abandon oxidative metabolism, dismantling their mitochondrial functions over time.

Mitochondrial Dysfunction and Cancer

• There’s a debate regarding whether mutations or dysfunctional mitochondria cause cancer; research indicates that damaged mitochondria hinder normal cell function.

• If mitochondria are severely damaged, apoptosis (controlled cell death) should occur. Aspirin may facilitate this process by promoting apoptosis in compromised cells.

Aspirin's Role in Cancer Treatment

• Historical studies show that aspirin can switch off cancer metabolism in relatively normal cells while inducing apoptosis in severely damaged ones.

• A study indicated that daily aspirin intake led to significant changes in cancerous tissues by restoring normal metabolic pathways or triggering cell death.

pH Levels and Apoptosis

• Cancer cells tend to be alkaline; for them to undergo apoptosis, they need an acidic environment—something aspirin can provide due to its acidic nature.

• The ability of a cancer cell to recognize its damage level influences whether it commits suicide or attempts metabolic recovery through oxidative phosphorylation.

Glycolysis vs. Oxidative Phosphorylation

• Glycolysis serves as a backup energy pathway but is less efficient than oxidative phosphorylation, producing harmful byproducts like lactic acid.

• In some cancer cells with damaged electron transport chains, committing apoptosis becomes essential since they cannot perform effective energy production anymore.

Aspirin and Cellular Mechanisms

Role of Aspirin in Cell Death

• Aspirin aids in the process of apoptosis (cell death) by altering pH levels, which is crucial for damaged cells to commit to this process.

• An acidic pH is necessary for apoptosis; aspirin is one method to achieve this, alongside carbon dioxide, which acts as a Lewis acid.

Exploring Alternatives to Aspirin

• The speaker discusses their inquiry with Dr. Pete regarding enhancing aspirin's effectiveness for cancer treatment, specifically considering more acidic and lipophilic compounds.

• They discovered 26-hydroxybenzoic acid, a metabolite of aspirin that may offer greater benefits than aspirin itself due to its properties.

Understanding Cancer from an Evolutionary Perspective

• A notable cancer researcher proposed viewing cancer not merely as a disease but as a regression to primitive cellular functions reliant on glycolysis.

• The mitochondria are described as once being independent organisms that formed a symbiotic relationship with primitive human cells, enabling complex life through energy production.

Impacts of Mitochondrial Dysfunction

• Disruption of the mitochondrial symbiosis leads cells back to basic glycolytic functions, limiting energy production solely for growth and division.

• This regression can be likened to bacterial or fungal behavior where cells consume their environment indiscriminately.

Environmental Factors Affecting Mitochondria

• Various factors can disrupt mitochondrial function including physical injuries and chemical assaults like endocrine disruptors and radiation exposure.

• Non-ionizing radiation from modern technology (e.g., phones, fluorescent lights) poses risks by damaging mitochondria over prolonged exposure.

Consequences of Mitochondrial Damage

• Blue light exposure is highlighted as harmful; it can lead to cognitive disturbances and potentially mental health issues due to its toxic effects on mitochondria.

• Prolonged interference with mitochondrial function may result in the host cell dismantling these organelles, leading ultimately to severe health consequences such as cancer.

Metabolic Processes and Cancer Research

Overview of Metabolism

• The phosphorylation process occurs entirely in the mitochondria, while glycolysis takes place outside. Oxidative phosphorylation happens inside the mitochondria through the electron transport chain.

• The primary goal of metabolism is to convert energy from food into cellular energy, specifically ATP, utilizing high-energy electrons and various co-factors like vitamins and minerals.

Role of Co-Factors in Energy Production

• Previous studies indicate that aspirin and its metabolite can restore electron flow; B vitamins (B1 and B3) are also crucial for energy production as they may be missing co-factors in cancer cells.

Recent Cancer Studies

• The speaker discusses recent investigations into oxidative phosphorylation restoration, focusing on breast cancer (MCF-7 cell line) and prostate cancer studies.

• MCF-7 is a widely studied estrogen receptor-positive cell line, relevant due to its prevalence in breast cancer diagnoses.

Study Findings on Treatment Combinations

• The study involved groups treated with combinations of B vitamins plus aspirin, just aspirin's metabolite (26 DHPA), and pregnanolone.

• Pregnanolone showed superior effectiveness compared to standard treatments like tamoxifen without causing cell toxicity or damage.

In Vivo Study Results

• An in vivo study using human tumors transplanted into immunocompromised mice indicated that treatment with aspirin plus B vitamins or pregnanolone halted tumor growth, showing signs of regression without toxicity.

Future Directions and Expectations

• If tumors completely disappear after treatment cessation, it will be considered full remission. Previous studies with other cancers have shown promising results regarding long-term outcomes post-treatment.

• Ongoing research includes lethal tumors such as pancreatic cancer and neuroblastoma alongside breast cancer studies to evaluate treatment efficacy further.

Understanding the Role of Pregnenolone in Cancer Treatment

Effectiveness of Pregnenolone Compared to Standard Treatments

• Pregnenolone shows significant effectiveness in treating cancer, performing equally or better than standard treatments within a few weeks without causing harm to the host.

• Unlike established treatments like tamoxifen and anastrozole, which exhibit toxicity, pregnenolone has been tested for cell toxicity with no adverse effects observed.

• The studies indicated that pregnenolone could revert cancerous cells' metabolism back to normal without killing them, highlighting its unique therapeutic potential.

Estrogen Dominance and Its Implications

• Estrogen dominance is increasingly prevalent due to environmental factors such as pesticides and phytoestrogens found in foods like soy and flax.

• This condition interferes with oxidative phosphorylation, crucial for energy production; understanding this relationship is vital for addressing metabolic dysfunction.

Mechanisms of Action: Estrogen vs. Carbon Dioxide

• Estrogen acts as a reductant, leading to an overproduction of reactive oxygen species (ROS), which can dismantle mitochondrial function.

• In contrast, carbon dioxide promotes oxidation by drawing electrons across the cell membrane, enhancing oxidative phosphorylation reactions.

Lactate Production and Mitochondrial Dysfunction

• Elevated lactate levels result from blocked glucose oxidizing enzymes like pyruvate dehydrogenase, contributing to cancer progression by promoting new blood vessel formation.

• Chronic lactate overproduction signals cells to dismantle their mitochondria, leading to severe dysfunction often seen in precursors to cancer such as type 2 diabetes.

Energy Metabolism: Fat vs. Glucose Utilization

• Excessive lactate accumulation acts as a metabolic poison; it hampers energy production and leads to fatigue and poor recovery from exertion.

• Estrogen stimulates lipolysis but creates competition between fat and glucose oxidation; this imbalance prevents proper glucose utilization in cancer cells.

Understanding Cancer Metabolism and Treatment Challenges

The Misconception of Sugar Feeding Cancer

• The belief that cancer feeds off sugar is a misunderstanding; cancer cells waste carbohydrates instead of utilizing them effectively.

• In healthy cells, glucose undergoes glycolysis to produce pyruvate, which then enters the mitochondria for further energy production.

• If pyruvate cannot enter the mitochondria due to blockages, it accumulates, leading to potential cell death if glycolysis ceases.

Cellular Responses to Metabolic Blockage

• Cells in a state of extreme reduction build up pyruvate and NADH, which is crucial for mitochondrial function.

• When NADH accumulates excessively, the cell attempts to convert it back into NAD+ using pyruvate instead of oxygen, resulting in lactate production.

Consequences of Killing Cancer Cells

• The only ways out of this cycle are restoring mitochondrial function or inducing apoptosis in severely damaged cells.

• Aggressive treatments like chemotherapy can inadvertently harm relatively healthy cells, causing systemic inflammation as they release cellular debris into the bloodstream.

Systemic Effects of Inflammation from Cell Death

• This inflammation triggers pathways similar to those activated during infections, leading to chronic inflammation that disrupts oxidative phosphorylation throughout the body.

• As a result, killing cancer cells can lead to an environment conducive for new cancer growth rather than eliminating existing tumors.

The Challenge of Metastasis Post-Treatment

• After aggressive treatment methods like radiation and chemotherapy, patients often experience metastasis as their bodies shift towards a cancerous metabolic state.

• Oncologists face challenges because while they can kill primary tumors effectively, these treatments may provoke widespread metastatic disease.

Rethinking Cancer Treatment Strategies

• Instead of immediate aggressive treatment strategies aimed at destruction, there should be efforts focused on coaxing cancer cells back toward normal functioning.

• Many cancer cells remain structurally normal but metabolically deranged; thus metabolic approaches could help restore balance without triggering systemic damage.

Understanding Cancer Metabolism and Hormonal Influence

The Impact of Cancer Cell Assault on Surrounding Cells

• When cancer cells are aggressively targeted, it triggers a response from surrounding healthy cells, mobilizing resources towards the cancer's metabolism.

• This reaction can lead to the formation of metastatic nodules throughout the body as healthy cells adapt to support cancerous growth.

The Concept of "Healthy" Cancer Cells

• The idea of a "healthy cancer cell" contrasts with mainstream beliefs; these cells possess potential for recovery by reactivating energy production mechanisms.

• Estrogen dominance disrupts pyruvate's entry into the electron transport chain, impairing ATP production and leading to mitochondrial dysfunction.

Role of Pregnenolone in Hormonal Balance

• Pregnenolone is identified as an upstream hormone that can help mitigate estrogen dominance locally within tissues.

• It acts as an aromatase inhibitor, limiting new estrogen synthesis across various tissues where aromatase enzymes are present.

Aromatase Inhibition and Cancer Treatment

• Aromatase inhibitors are standard treatments for estrogen receptor-positive breast cancer, reducing estrogen levels both locally and systemically.

• Pregnenolone has been compared to established aromatase inhibitors like letrozole and anastrozole in studies focused on its efficacy against breast cancer.

Mechanisms of Estrogen Uptake Limitation

• Cancer cells can overproduce estrogen, which may affect neighboring healthy cells; thus, limiting local synthesis and external uptake is crucial.

• High doses of pregnenolone can significantly reduce both local estrogen production and its absorption from the bloodstream into target cells.

Dosage Insights from Research Studies

• Current mouse studies suggest a dosage equivalent of 200 mg/kg daily for pregnenolone; this translates roughly to 15 mg/kg for humans.

• Historical accounts indicate that high doses (several grams daily) have been used effectively without toxicity in certain cases.

Stabilization Effects of Pregnenolone

• Pregnenolone appears most effective when there is a steroid imbalance further down the hormonal cascade; otherwise, it remains largely inactive but still stabilizes cellular integrity.

• As a lipophilic steroid, pregnenolone enhances cell membrane impermeability against external assaults.

Understanding Endocrine Disruptors and Hormonal Balance

Mechanism of Endocrine Disruptors

• Endocrine disruptors must enter the body, be distributed via blood, and penetrate cells to cause damage. The lipophilicity of a cell affects its vulnerability to these agents.

Lipophilicity and Cell Vulnerability

• Highly lipophilic cells are more resistant to external attacks; saturated fats increase this property, while polyunsaturated fatty acids (PUFAs) are more hydrophilic due to their double bonds. This makes cells more susceptible to harmful substances.

Impact of PUFAs on Cellular Health

• High PUFA intake can lead to increased cellular vulnerability as they diffuse into cells, allowing damaging molecules easier access for harm over time. This exacerbates health issues related to estrogen dominance.

Estrogen Detoxification Challenges

• PUFAs interfere with the liver's ability to detoxify estrogen, worsening conditions associated with excess estrogen in the body, particularly in tumor tissues where estrogen acts as a growth promoter. Vitamins B1, B2, and B3 play crucial roles in this detoxification process.

Role of Vitamins in Estrogen Detoxification

• Essential vitamins assist the liver in detoxifying excess estrogen produced by tumors; this is critical since tumors rely on estrogen for growth and proliferation. Vitamin deficiencies can hinder this detoxification process significantly.

Pregnenolone vs Progesterone: A Comparative Analysis

• Pregnenolone is considered inactive unless there’s an issue within the body; it serves as a mild aromatase inhibitor but lacks direct action on estrogen receptors compared to progesterone which actively blocks them and has additional anti-inflammatory effects.

Accessibility of Hormonal Treatments

• Pregnenolone is more widely accessible than progesterone, which is often regulated like anabolic steroids in many countries; thus, pregnenolone may serve as a safer alternative for individuals seeking hormonal balance without prescription barriers.

Recommendations for Cancer Management

• For established cancers beyond stage one, progesterone may be preferred due to its stronger aromatase inhibition and direct blockade of estrogenic activity compared to pregnenolone which does not act directly on these receptors. Additionally, combining treatments like aspirin could enhance therapeutic outcomes against cancer-related inflammation caused by estrogens.

Pregnenolone and Prostate Cancer: Insights from Research

Optimal Dosage of Pregnenolone

• The speaker suggests that a lower dose of pregnenolone, around 30 milligrams daily, is effective for general preventive purposes. This aligns with personal experiences shared by Ry.

• An optimal dosage range of 10 to 30 milligrams daily is recommended, especially when combined with aspirin. The speaker emphasizes this as a personal approach rather than an official recommendation.

Prostate Cancer Study Overview

• The prostate cancer study discussed was conducted using progesterone instead of pregnenolone. The primary goals were to demonstrate that androgens are not the cause but can be therapeutic.

• It is highlighted that estrogen plays a significant role in prostate cancer development, countering the common belief that androgens like dihydrotestosterone (DHT) are solely responsible.

Androgens vs. Estrogen in Prostate Cancer

• Urologists often attribute prostate cancer to DHT; however, the speaker proposes reversing this narrative by administering estrogen to patients.

• Ethinyl estradiol, a synthetic estrogen used in contraceptive treatments, is mentioned as part of the study's methodology.

PCOS and Hormonal Interactions

• There’s a parallel drawn between findings on PCOS and prostate cancer; both conditions involve complex interactions between estrogens and androgens.

• Studies indicate that high doses of DHT did not worsen PCOS symptoms in women but instead led to weight loss and improved mood.

Importance of Androgens Across Genders

• Research shows that without androgens, both male and female organisms become sterile. Experiments with genetically modified chickens illustrate this point effectively.

• The removal of androgen leads to infertility in males as well, emphasizing the systemic importance of these hormones across genders.

Standard Care for Prostate Cancer

• Current standard care involves chemical castration through hormonal manipulation while paradoxically using estrogen as part of treatment protocols.

• There’s criticism regarding how medicine frames androgen removal as necessary for treating prostate cancer while simultaneously administering estrogen which may contribute to its progression.

This structured summary encapsulates key discussions surrounding pregnenolone's use in preventive health measures, insights from research on prostate cancer treatment methodologies involving hormones, and broader implications regarding hormonal balance across genders.

The Impact of Estrogen on Cancer and Aging

The Role of Estrogen in Hormonal Regulation

• High doses of estrogen can chemically castrate both men and women by suppressing androgen production in males and progesterone in females.

• Elevated estrogen levels lead to feminization in males and masculinization in females, diminishing sexual dimorphism, particularly noticeable in older individuals.

Aging and Hormonal Changes

• Estrogen is one of the few hormones that does not decline with age, alongside cortisol; other youth-promoting hormones significantly decrease.

• High cortisol levels can accelerate aging symptoms, while elevated estrogen may contribute to a loss of sexual differentiation and reduced cellular energy production.

Rising Cancer Rates Among Younger Populations

• There is a concerning increase in cancer rates among individuals under 30, particularly for cancers traditionally associated with older age groups (e.g., lung, colon).

• This trend suggests environmental factors rather than genetic mutations are influencing these rising cancer rates.

Experimental Findings on Prostate Cancer Treatment

• In experiments where dihydrotestosterone (DHT) was administered alongside an aromatase inhibitor, tumor sizes decreased unexpectedly instead of increasing as predicted by conventional medicine.

• A combination treatment resulted in complete remission of tumors, challenging existing medical beliefs about hormone therapy's effects on cancer growth.

Alternative Treatments and Observations

• Other anti-estrogenic treatments like progesterone also showed zero tumor size growth, indicating potential effectiveness against prostate cancer.

• Current medical practices involving castration for prostate cancer management have been shown to lead to aggressive forms of the disease returning after initial shrinkage.

Prostate Cancer Treatment: A Controversial Perspective

The Impact of Androgens on Prostate Cancer

• The quality of life for patients with advanced prostate cancer is severely compromised, often leading to untreatable forms like castration-resistant cancer, which is typically fatal.

• Recent studies show that injecting testosterone directly into the prostates of terminally ill patients can lead to tumor disappearance, contradicting mainstream beliefs about androgens exacerbating cancer.

• This phenomenon has been termed "rejuvenating andro shock therapy," suggesting that androgens can revert castration-resistant cells back to a sensitive state, challenging existing treatment paradigms.

Challenging Mainstream Cancer Models

• There is a growing body of evidence indicating that the conventional understanding of prostate cancer—specifically the role of estrogen—is fundamentally flawed; testosterone may actually counteract cancer progression.

• The speaker emphasizes caution in discussing these findings due to potential backlash from established medical practices and possible legal repercussions for advocating against mainstream treatments.

Historical Context and Evidence

• An article written 30 years ago highlighted how estrogen drives cancer metabolism while testosterone opposes its effects. Despite initial positive results from testosterone treatment, it did not lead to significant changes in medical practice or public perception.

• Doctors rationalized the success of testosterone injections by claiming they converted into estrogen within the body, thus maintaining their stance against direct androgen use despite contradictory evidence.

Mechanisms Behind Testosterone's Effects

• The argument presented suggests inconsistency in claims regarding testosterone's role in cancer growth; either it is harmful or beneficial depending on context, particularly when injected directly into prostate tissue.

• Prostate cells exhibit low levels of aromatase enzyme expression, meaning that injected testosterone does not significantly convert to estrogen within the prostate itself. Instead, dihydrotestosterone (DHT), produced from testosterone via another enzyme (5 alpha reductase), may have therapeutic properties.

Profit Motives and Estrogen Therapy

• The discussion touches upon financial incentives behind estrogen therapies; these treatments are highly profitable for pharmaceutical companies and are widely used in various medical contexts including abortion procedures.

• Historical practices reveal that high-estrogen foods were utilized in livestock management to prevent unwanted births, indicating long-standing awareness of estrogens' biological impacts.

Understanding the Role of Estrogen and Androgens in Prostate Cancer

The Dangers of Estrogen

• Animals consuming high levels of phytoestrogens may experience spontaneous abortion, indicating estrogen's potent abortive properties.

• Externally administered estrogen is discouraged as the body naturally produces sufficient amounts; excess can be harmful.

Androgens vs. Estrogens in Prostate Health

• The argument that androgens cause prostate cancer is challenged; young males with low estrogen and high androgen levels do not commonly develop prostate cancer.

• A healthy androgen to estrogen ratio (at least 50:1 favoring androgens) is crucial for male health, preventing chronic conditions like liver disease and infertility.

Misconceptions About Prostate Cancer Treatment

• Current medical advice suggests that a higher androgen to estrogen ratio is detrimental for prostate cancer, leading to misguided treatments that involve reducing androgens.

• Despite aggressive treatment approaches, such as castration and increased estrogen administration, there has been no significant decline in prostate cancer rates.

Watchful Waiting Approach

• Most urologists now recommend "watchful waiting" for men diagnosed with non-aggressive prostate cancer rather than immediate intervention.

• Many men live with undiagnosed localized cancers without issues; they are more likely to die from other causes than from this type of cancer.

The Risks of Aggressive Treatments

• Aggressive treatments may initially shrink tumors but often lead to more aggressive forms of treatment-resistant prostate cancer over time.

• Historical autopsy studies revealed that nearly all men over 35 have detectable tumor nodules in their prostates, which typically remain asymptomatic unless treated aggressively.

Rethinking Cancer Treatment Paradigms

• Interventions targeting healthy cells can provoke adverse reactions; creating an inhospitable environment for still viable cells may lead them to become more aggressive.

• Emerging research suggests that increasing androgen exposure instead of reducing it could potentially reverse tumor growth contrary to mainstream beliefs about estrogens being beneficial.

Environmental Factors Contributing to Cancer Rates

• Rising cancer rates correlate with increased exposure to environmental estrogens from various sources including pesticides and plastics, raising questions about current treatment strategies.

Chronic Disease Management and the Challenges of Publication

Importance of Managing Chronic Diseases

• The discussion highlights that managing chronic diseases, such as cancer, is often more feasible than curing them. This sets the stage for exploring alternative treatments.

Concerns Over Safety and Information Dissemination

• Sarah expresses concern for Georgie's safety while discussing critical information that may not be widely shared. This indicates a potential risk associated with revealing sensitive health-related insights.

Paradigm Shifts in Medical Research

• The conversation touches on the idea of presenting new findings as a paradigm shift, particularly regarding Dr. Serotonin and SSRIs, suggesting a significant change in understanding treatment approaches.

Challenges in Publishing New Research

• Georgie shares his hesitance to publish due to concerns about backlash from established medical journals and the powerful cancer industry. He notes that many journals require human trial confirmations before considering publication.

• There is an acknowledgment that publishing controversial studies can lead to retraction threats, which could damage researchers' reputations and future publishing opportunities.

Grassroots Movements in Cancer Treatment

• Despite challenges, Georgie mentions grassroots movements where doctors are already applying new research on patients with various cancers using B vitamins and aspirin. This suggests a growing acceptance outside traditional channels.

• He cites an oncologist from Ireland who claims success in treating patients with tumors using these methods, emphasizing the importance of sharing this information broadly without formal publication constraints.

Providing Resources for Patients

• The podcast hosts discuss compiling a list of healthcare professionals knowledgeable about these treatments to assist listeners seeking help, indicating community support for those interested in alternative therapies.

Funding Support for Alternative Treatments

• Georgie addresses inquiries about funding his work through Idealabs.com but expresses reluctance towards donations without tangible exchanges like product purchases. This reflects his commitment to maintaining integrity in transactions related to health products.

• He emphasizes providing supplements directly rather than accepting donations, reinforcing his belief in fair transactions where customers receive value for their contributions.

Clinical Trials and Funding for Cancer Studies

Overview of Clinical Trials

• Discussion on the initiation of clinical trials, emphasizing that a doctor must oversee these processes due to regulatory requirements.

• Mention of potential collaboration with a university in the U.S. for conducting limited clinical trials, highlighting the need for funding through donations rather than institutional support.

Funding Mechanisms

• The speaker indicates that donations will be crucial for financing non-governmental and non-private industry-funded trials, as universities typically do not cover these costs themselves.

• Introduction of a product containing aspirin-like molecules intended for skin protection, noting it is not available as a standalone product currently.

Support for Cancer Research

• Encouragement to support cancer studies by purchasing supplements from Ideal Labs, which are used to fund transformative research efforts.

• Plans to follow up on tumor size reduction results in future discussions, expressing gratitude towards Georgie’s contributions and optimism about helping others through this research.

Future Engagement

• A commitment to schedule further discussions regarding ongoing developments in cancer studies and outcomes related to treatment efficacy.